Lupin India’s most reputed drug brand; Sun, Cipla follow

Domestic pharmaceuticals firms Lupin, Sun Pharmaceuticals and Cipla have dominated the list of top reputed pharmaceutical companies in a brand survey released on Wednesday.

Mumbai-based Lupin Pharmaceuticals tops in reputation as it leads the country's most reputed pharmaceutical brands' list, as per a 'Top Most Reputed Pharmaceutical Brand' study conducted by BlueBytes in association with TRA Research.

Sun Pharmaceutical, with a 52 per cent Brand Rep Score and Cipla with 28 per cent bagged the second and third spots, followed by Dr Reddy's Laboratories at fourth.

At India's fourth position in 'Most Reputed Pharma Brand' is Dr.Reddy's, behind 71 per cent in terms of Brand Rep points. Among global brands GSK leads the way followed by Pfizer with a Brand Rep Score 73 per cent below the leader among International pharmaceutical companies. Abbott's Brand Rep Score was 12 per cent lower, ranking it India's 3rd Most Reputed among International brands.

There were 41 domestic and 17 international pharmaceutical brands listed in the study. The study evaluates a brand's Brand Reputation by analysing media perception and consumer perceptions.

"India's reputation as the largest producer of generic drugs in the world has become vulnerable in the light of the changing patent regime in the country. Reports say that by 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. Given the importance of this sector for the economy and to the public, brands should concentrate on building and maintaining their Reputation to stay ahead in the changing world," said Pooja Kaura, chief spokesperson for India's Most Reputed Brands.